Total Payments
$8,201
2024 Payments
$1,641
Companies
32
Transactions
490
Medicare Patients
1,491
Medicare Billing
$310,632
Payment Breakdown by Category
Food & Beverage$7,961 (97.1%)
Education$239.57 (2.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,961 | 483 | 97.1% |
| Education | $239.57 | 7 | 2.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $2,284 | 136 | $0 (2024) |
| Novo Nordisk Inc | $1,073 | 57 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $937.69 | 53 | $0 (2024) |
| PFIZER INC. | $726.11 | 56 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $529.35 | 46 | $0 (2022) |
| Lilly USA, LLC | $461.82 | 22 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $295.93 | 19 | $0 (2022) |
| Astellas Pharma US Inc | $280.59 | 6 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $274.17 | 17 | $0 (2023) |
| Bayer Healthcare Pharmaceuticals Inc. | $177.30 | 10 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,641 | 80 | Novo Nordisk Inc ($403.37) |
| 2023 | $1,410 | 71 | GlaxoSmithKline, LLC. ($365.58) |
| 2022 | $1,041 | 57 | GlaxoSmithKline, LLC. ($360.46) |
| 2021 | $632.49 | 42 | GlaxoSmithKline, LLC. ($340.52) |
| 2020 | $375.19 | 23 | GlaxoSmithKline, LLC. ($180.07) |
| 2019 | $1,245 | 76 | GlaxoSmithKline, LLC. ($306.45) |
| 2018 | $872.42 | 70 | GlaxoSmithKline, LLC. ($222.37) |
| 2017 | $984.21 | 71 | Janssen Pharmaceuticals, Inc ($164.17) |
All Payment Transactions
490 individual payment records from CMS Open Payments — Page 4 of 20
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/18/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $21.53 | General |
| Category: RESPIRATORY | ||||||
| 01/12/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.27 | General |
| Category: Cardio-renal | ||||||
| 01/11/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $21.05 | General |
| Category: Diabetes | ||||||
| 01/09/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $24.46 | General |
| Category: NEUROSCIENCE | ||||||
| 01/02/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.53 | General |
| Category: RESPIRATORY | ||||||
| 12/19/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $19.35 | General |
| Category: RESPIRATORY | ||||||
| 12/18/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $23.36 | General |
| Category: Diabetes | ||||||
| 12/06/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $25.77 | General |
| Category: Biological | ||||||
| 12/05/2023 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $20.67 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 11/30/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $21.31 | General |
| Category: Respiratory | ||||||
| 11/21/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $23.80 | General |
| Category: RESPIRATORY | ||||||
| 11/15/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $25.74 | General |
| Category: Diabetes | ||||||
| 11/14/2023 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $15.61 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 11/10/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.91 | General |
| Category: DIABETES | ||||||
| 10/30/2023 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $20.80 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 10/27/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $21.16 | General |
| Category: Diabetes | ||||||
| 10/26/2023 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.52 | General |
| Category: Diabetes | ||||||
| 10/11/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $20.34 | General |
| Category: RESPIRATORY | ||||||
| 10/10/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $23.39 | General |
| Category: Respiratory | ||||||
| 10/06/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY, SHINGRIX | Food and Beverage | In-kind items and services | $22.00 | General |
| Category: RESPIRATORY | ||||||
| 10/06/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $19.13 | General |
| Category: Cardio-renal | ||||||
| 10/04/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $20.92 | General |
| Category: Diabetes | ||||||
| 10/03/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $25.78 | General |
| Category: Diabetes | ||||||
| 10/02/2023 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $15.95 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 10/01/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY, SHINGRIX | Food and Beverage | In-kind items and services | $21.09 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 317 | 1,274 | $110,528 | $70,196 |
| 2022 | 4 | 338 | 1,464 | $126,670 | $81,015 |
| 2021 | 2 | 342 | 1,590 | $136,230 | $88,751 |
| 2020 | 6 | 494 | 1,676 | $145,180 | $70,670 |
Total Patients
1,491
Total Services
6,004
Medicare Billing
$310,632
Procedure Codes
16
All Medicare Procedures & Services
16 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 264 | 1,218 | $103,555 | $65,981 | 63.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 23 | 26 | $3,420 | $2,474 | 72.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 13 | 13 | $1,460 | $1,007 | 68.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 17 | 17 | $2,093 | $734.59 | 35.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 283 | 1,407 | $119,595 | $76,244 | 63.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 22 | 24 | $3,140 | $2,475 | 78.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 18 | 18 | $2,125 | $1,255 | 59.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 15 | 15 | $1,810 | $1,041 | 57.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 316 | 1,558 | $132,440 | $85,902 | 64.9% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 26 | 32 | $3,790 | $2,850 | 75.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 324 | 1,459 | $124,105 | $65,776 | 53.0% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 23 | 25 | $2,750 | $1,803 | 65.6% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 23 | 23 | $2,550 | $1,071 | 42.0% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 22 | 25 | $2,375 | $1,026 | 43.2% |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic | Office | 2020 | 89 | 130 | $12,350 | $844.16 | 6.8% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2020 | 13 | 14 | $1,050 | $149.11 | 14.2% |
About Dr. George Siniapkin, MD
Dr. George Siniapkin, MD is a Specialist healthcare provider based in Corinth, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1518052828.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. George Siniapkin, MD has received a total of $8,201 in payments from pharmaceutical and medical device companies, with $1,641 received in 2024. These payments were reported across 490 transactions from 32 companies. The most common payment nature is "Food and Beverage" ($7,961).
As a Medicare-enrolled provider, Siniapkin has provided services to 1,491 Medicare beneficiaries, totaling 6,004 services with total Medicare billing of $310,632. Data is available for 4 years (2020–2023), covering 16 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Location Corinth, NY
- Active Since 10/03/2006
- Last Updated 07/08/2007
- Taxonomy Code 174400000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1518052828
Products in Payments
- TRELEGY ELLIPTA (Drug) $1,694
- FARXIGA (Drug) $557.15
- XARELTO (Drug) $434.95
- ANORO (Drug) $400.57
- Ozempic (Drug) $351.05
- Rybelsus (Drug) $332.83
- CHANTIX (Drug) $259.25
- MOUNJARO (Drug) $238.36
- AIRSUPRA (Drug) $204.20
- NURTEC ODT (Drug) $202.08
- TRULICITY (Drug) $186.32
- JARDIANCE (Drug) $185.23
- Kerendia (Drug) $177.30
- UBRELVY (Drug) $150.92
- YUPELRI (Drug) $131.85
- Tresiba (Drug) $127.21
- SOLIQUA (Drug) $125.50
- Victoza (Drug) $120.44
- BREZTRI (Drug) $119.80
- BREO (Drug) $119.78
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.